Conference Proceedings

An Improved Benefit-Risk Profile of Duvelisib in Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Received >= 2 Prior Therapies

Matthew Davids, Peter Hillmen, Marco Montillo, Julio Delgado, Bryone Kuss, Constantine Tam, Ulrich Jaeger, Paolo Ghia, Stephan Stilgenbauer, Florence Cymbalista, Stephanie Lustgarten, David Weaver, Hagop Youssoufian, Ian Flinn

Clinical Lymphoma Myeloma and Leukemia | CIG MEDIA GROUP, LP | Published : 2019